XWELL, Inc. - Common Stock (NQ:XWEL)

0.8250 -0.0129 (-1.54%)

Delayed Quote Updated: 9:30 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about XWELL, Inc. - Common Stock

< Previous 1 2 3 4 Next >

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session ↗

June 10, 2025

Via Benzinga

12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session ↗

May 20, 2025

Via Benzinga

12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session ↗

May 14, 2025

Via Benzinga

12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session ↗

April 09, 2025

Via Benzinga

XWEL Stock Earnings: XWELL Reported Results for Q2 2024 ↗

August 14, 2024

XWELL just reported results for the second quarter of 2024.

Via InvestorPlace

XWEL Stock Earnings: XWELL Reported Results for Q1 2024 ↗

May 15, 2024

XWELL just reported results for the first quarter of 2024.

Via InvestorPlace

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session ↗

December 24, 2024

Via Benzinga

12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session ↗

December 18, 2024

Via Benzinga

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session ↗

December 17, 2024

Via Benzinga

ThredUp And 2 Other Stocks Under $2 Executives Are Buying ↗

September 16, 2024

Via Benzinga

Apple, ScanSource And 3 Stocks To Watch Heading Into Tuesday ↗

August 27, 2024

Via Benzinga

Earnings Scheduled For November 14, 2024 ↗

November 14, 2024

Via Benzinga

CPC Issues Letter to Fellow XWELL, Inc. Shareholders Revealing Intention Behind Recent Schedule 13D Filing & Lawsuit Against Entrenched Board of Directors

July 24, 2024

From CPC Pain & Wellness SPV LLC

Via GlobeNewswire

XWELL Announces Director Candidate Nomination Notice Submitted by CPC is Invalid

July 22, 2024

From XWELL, Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

July 18, 2024

Pre-market stock movers are worth diving into this morning and we have all of the hottest news worth checking out on Thursday!

Via InvestorPlace

XWEL Stock Earnings: XWELL Misses EPS, Misses Revenue for Q4 2023 ↗

April 16, 2024

XWEL stock results show that XWELL missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session ↗

April 04, 2024

Via Benzinga

11 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session ↗

April 01, 2024

Via Benzinga

12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session ↗

March 20, 2024

Via Benzinga

12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session ↗

February 26, 2024

Via Benzinga

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session ↗

January 18, 2024

Via Benzinga

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session ↗

January 02, 2024

Via Benzinga

12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session ↗

December 06, 2023

Via Benzinga

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session ↗

November 16, 2023

Via Benzinga

12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session ↗

November 16, 2023

Via Benzinga

12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session ↗

October 12, 2023

Via Benzinga

12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session ↗

October 11, 2023

Via Benzinga

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session ↗

October 10, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 29, 2023

Friday's session saw 112 companies set new 52-week lows.

Via Benzinga

Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 28, 2023

Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.